Opioid-Free Pain Protocol After Shoulder Arthroplasty
Running, not enrolling · Phase 4
Conditions studied: Shoulder Arthropathy, Shoulder Pain
In brief
This randomized, single blinded, clinical trial aims to investigate the efficacy of a multimodal pain control regimen for shoulder arthroplasty. Patients who receive a multimodal pain control regimen alone (study group) will be compared to patients who receive a multimodal pain control regimen plus a standard prescription of an opioid containing medication (comparison group). The primary outcome is average daily Numerical Rating Scale (NRS) pain score in the first 10 days after surgery. We hypothesize that there will be no significant difference in the primary outcome between the two groups.
Key facts
- Study ID
- NCT05488847
- Run by
- Henry Ford Health System
- People needed
- 83
- Starts
- 2022-06-25
- Expected to finish
- 2026-09-01
- Last updated by the study team
- 2026-02-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Consented and scheduled for primary anatomic or reverse total shoulder arthroplasty at a Henry Ford hospital location
You may not qualify if…
- Unable to receive or reply to mobile phone text messages.
- Unable to read or speak English
- Medical history of known allergies or intolerance to any of the medications prescribed as a part of this study (ie, Percocet, Ibuprofen, Pregabalin, Dexamethasone, Acetaminophen, Tizanidine, Magnesium, Celecoxib, Tramadol, Ropivacaine, Epinephrine, Ketorolac)
- Substantial alcohol or drug abuse
- Recent or current pregnancy
- History of narcotic use within 3 months prior to surgery
- Renal or hepatic impairment or dysfunction
- Use of blood thinner medication
- Peptic ulcer disease
- Gastrointestinal bleeding
- History of gastric bypass surgery
Where it is running
- Henry Ford Health — Detroit, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.